Produkty 2242-65-1

CAS 2242-65-1 występuje w naszej ofercie pod nazwami: Medroxyprogesterone Acetate EP Impurity D (Megestrol Acetate EP Impurity F), Megestrol Acetate Impurity 6（Megestrol Acetate EP Impurity F）, 6-epi-Medroxy Progesterone 17-Acetate, >95% (HPLC), epi-Medroxy progesterone 17-acetate. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, Biosynth. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 1mg, 2mg.

Medroxyprogesterone Acetate EP Impurity D (Megestrol Acetate EP Impurity F)
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Megestrol Acetate Impurity 6（Megestrol Acetate EP Impurity F）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
6-epi-Medroxy Progesterone 17-Acetate, >95% (HPLC)
TRC
  • opakowanie: 10mg, 1mg
  • Warianty: 2
Zobacz produkt
epi-Medroxy progesterone 17-acetate
Biosynth
  • opakowanie: 2mg, 1mg, 5mg, 10mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate (CAS 2242-65-1) to związek chemiczny o wzorze sumarycznym C24H34O4 i masie molowej 386.5 g/mol. Nazwa systematyczna IUPAC: [(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate. InChIKey: PSGAAPLEWMOORI-BMHIUQAOSA-N.

Dane identyfikacyjne
Wzór sumarycznyC24H34O4
Masa molowa386.5 g/mol
Nazwa IUPAC[(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
InChIKeyPSGAAPLEWMOORI-BMHIUQAOSA-N
SMILESC[C@@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 6-Epimedroxyprogesterone acetate, Megestrol acetate impurity F [EP], 6beta-Methyl-3,20-dioxopregn-4-en-17-yl acetate, 6beta-Methyl-17alpha-hydroxyprogesterone acetate, Medroxyprogesterone acetate specified impurity D [EP], Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6beta)-, MEGESTROL ACETATE IMPURITY F [EP IMPURITY], MEDROXYPROGESTERONE ACETATE IMPURITY D [WHO-IP], MEDROXYPROGESTERONE ACETATE IMPURITY D [EP IMPURITY], MEGESTROL ACETATE IMPURITY F (EP IMPURITY)
Powiązane formy tego związku
[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C24H34O4
[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-6-(trideuteriomethyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] 2,2,2-trideuterioacetate C24H34O4
Izomery (ten sam wzór sumaryczny)
[(2E,4E,6E,8E)-9-(4-acetyloxy-2,6,6-trimethylcyclohexen-1-yl)-3,7-dimethylnona-2,4,6,8-tetraenyl] acetate C24H34O4
6-[4-[4-(6-hydroxyhexoxy)phenyl]phenoxy]hexan-1-ol C24H34O4
2-methyl-5,6-bis(trideuteriomethoxy)-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]cyclohexa-2,5-diene-1,4-dione C24H34O4
[(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate C24H34O4
(1R,2S,4R,8S,9S,12S,13R)-8-acetyl-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one C24H34O4
2,3-dimethoxy-5-methyl-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]cyclohexa-2,5-diene-1,4-dione C24H34O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-3-methoxy-10,13-dimethyl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C24H34O4
(1R,2R,4R,5R,7S,10R,11S,14S,15S,16S,18S,19S)-15-(3-hydroxyprop-1-ynyl)-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-5,7,15-triol C24H34O4
(1R,2R,4R,5R,10R,11S,14S,15S,16S,18S,19S)-5,5'-dihydroxy-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-15,2'-oxolane]-7-one C24H34O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C24H34O4